MedPath

ovel diagnostic markers for necrotising enterocolitis in the premature infant

Completed
Conditions
10017969
necrotising enterocolitis
Registration Number
NL-OMON34937
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Neonates with suspected necrotising enterocolitis

Exclusion Criteria

Abdominal wall defects, hyperbilirubinaemia necessitating intensive phototherapy

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>urine I-FABP/Claudin to Creatinine ratio, tissue oxygenation as measured via<br /><br>NIRS</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>inflammatory/metabolic markers such as WBC, CRP, TNFa, IL6 and IL10 and<br /><br>lactate/base excess as measured in blood and urine, location/quantity of FABP*s<br /><br>in the resected bowel and faecal cultures.</p><br>
© Copyright 2025. All Rights Reserved by MedPath